1. Taiwan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
CHC Healthcare Group

CHC Healthcare Group

TTWSE:4164
27.00
TWD
-0.25
(-0.92%)
5.59BMarket Cap
Nov 11Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
16.74
16.08
18.33
15.78
15.14
17.96
21.12
17.63
15.54
18.43
23.58
21.59
23.67
- -
Basic EPS, GAAP
2.41
2.04
1.73
1.14
-0.62
2.32
2.83
2.53
2.43
2.21
2.55
1.01
1
- -
Free Cash Flow per Basic Share
4.4
-1.9
2.48
3.5
0.4
-0.18
6.23
1.34
1.14
-0.16
2.35
-1.99
0.69
-0.81
Dividend per Share
2.92
2
2
2
1
1.1
1.79
1.94
2
2.01
1.97
2.09
1.44
- -
Book Value per Share
35.64
35.77
36.94
35.52
35.12
35.79
36.71
37.47
37.78
38.02
38.81
37.77
39.06
38.54
Tangible Book Value per Share
35.56
35.69
35.79
34.36
33.96
34.63
35.57
36.45
33.86
34.24
35.02
33.44
35.5
34.91
Basic Weighted Avg Shares
123
130
131
140
140
140
140
145
157
161
164
167
186
194
Sales/Revenue/Turnover
2,063
2,091
2,395
2,205
2,117
2,507
2,950
2,555
2,440
2,974
3,877
3,601
4,398
- -
Operating Margin (%)
19.21
17.86
15.44
13.97
16.67
16.46
17.3
20.12
20.23
16.14
15.83
6.57
9.34
- -
Depreciation Expense
339
353
389
398
432
429
412
441
461
499
594
634
659
- -
Net Income, GAAP
297
266
227
159
-87
323
395
366
382
357
419
168
186
- -
Effective Tax Rate (%)
22.73
18.68
21.28
29.48
- -
13.67
18.08
21.79
22.56
19.67
23.99
18.13
27.76
- -
Profit Margin (%)
14.39
12.71
9.46
7.21
-4.09
12.9
13.4
14.34
15.64
11.99
10.8
4.68
4.24
- -
Working Capital
858
740
2,087
317
1,238
1,852
460
2,432
2,298
2,798
2,906
1,274
2,315
2,146
LT Debt
1,066
1,814
3,486
2,263
3,514
3,990
2,113
3,780
3,995
4,581
4,592
3,140
3,638
3,719
Total Equity
4,663
4,691
5,566
4,969
4,914
5,134
5,317
6,000
6,314
6,403
6,776
6,672
8,050
7,863
Return on Invested Capital (%)
4.91
4.42
3.5
2.54
- -
4.18
4.86
4.37
3.51
3.34
3.95
1.59
2.21
- -
Return on Capital (%)
5.13
4.4
3.41
2.41
- -
4.23
5.24
4.73
4
3.36
4.1
1.92
1.78
- -
Return on Common Equity (%)
7.02
5.69
4.6
3.14
-1.75
6.54
7.8
6.66
6.4
5.83
6.65
2.64
2.67
- -

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,779
1,858
2,070
LT Borrowings
3,346
3,360
3,356
LT Finance Leases
293
291
364
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
195
195
194
Market Capitalization
7,519
5,889
5,591

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
4,985
5,191
5,233
Cash, Cash Equivalents & STI
1,854
1,641
1,525
Accounts Receivable, Net
1,034
1,100
1,152
Inventories
1,080
932
946
Total Current Liabilities
2,670
2,924
3,087
Payables & Accruals
- -
- -
- -
ST Debt
1,779
1,858
2,070
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.06%
6.32%
20.64%
Free Cash Flow
-595.25%
-407.41%
-138.93%
Net Income, GAAP
-67.67%
-6.82%
10.63%
Sales/Revenue/Turnover
7.35%
12.56%
22.15%
Total Cash Common Dividend
4.15%
-0.12%
-23.13%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
658
958
963
1,021
3,601
2025
1,008
1,082
- -
1,209
4,398
2026
1,160
1,178
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.17
0.56
0.27
1.01
2025
0.05
0.22
- -
0.36
1
2026
0.13
0.32
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
2.02
- -
2.09
2025
- -
- -
- -
- -
1.44
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Pei Lin Lee
Full Time Employees
386
Sector
Distribution services
Industry
Medical distributors
Address
No. 88, Xing'ai Road Taipei TPE Taiwan 114067
IPO Date
Oct 17, 2012
Website
chcg.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
CHC Healthcare Group is a Taiwan-based investment holding company engaged primarily in the distribution, sale, leasing, installation, and maintenance of a wide range of advanced medical equipment and healthcare products across Taiwan, China, and international markets. The company’s core offerings include radiation oncology equipment, neurology devices, medical imaging technologies, surgical instruments, ophthalmic equipment, dental supplies, robotic rehabilitation systems, and smart healthcare solutions. Additionally, CHC Healthcare Group provides pharmaceutical products and health food trading, consulting services, elderly care residences, senior fitness services, long-term care services, as well as leasing of veterinary medical instruments. The company manufactures and distributes prominent global medical brands such as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex, and Wexler, among others. Founded in 1977 and headquartered in Taipei City, Taiwan, CHC Healthcare Group operates with over 160 employees and maintains a leadership position in providing comprehensive healthcare management services for the Asia-Pacific region. The company emphasizes continuous introduction of new medical equipment and technologies, aiming to become a diversified distributor across multiple medical specialties. Recent strategic initiatives include accelerating the expansion of pharmacy channels, developing value-added services to enhance customer retention, and integrating resources to strengthen their competitive edge. The group also focuses on expanding professional technical expertise and increasing strategic partnerships to achieve greater economies of scale. In 2024, CHC Healthcare Group was recognized for excellence in corporate social responsibility for the fourth consecutive year. Recent major changes encompass the launch of new healthcare service offerings, including elderly-friendly housing and residential care service institutions, alongside ongoing resource integration and enlargement of sales channels for medical products. These strategic shifts reflect the company’s commitment to broadening its healthcare service scope and market share within the Asia-Pacific healthcare industry, leveraging its established network and technology introduction to maintain leadership in healthcare management and equipment distribution. The company continues to pursue growth through partnerships, new product introductions, and service diversification, maintaining a robust focus on technological advancement and service quality.